The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia

There are currently no regulatory approved pharmacological treatments for cognitive impairment associated with schizophrenia (CIAS). One possibility is that trial methodology itself is hindering their development. Emerging evidence suggests that patients with schizophrenia may show limited benefit f...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Jack Cotter, Jennifer H. Barnett, Kiri Granger
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2019-09-01
Ráidu:	Frontiers in Psychiatry
Fáttát:	clinical trial cognition pharmacotherapy psychosis schizophrenia trial methodology
Liŋkkat:	https://www.frontiersin.org/article/10.3389/fpsyt.2019.00648/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!